In re Suboxone Antitrust Litig., ___ F.3d ___ (3d Cir. 2020). In this antitrust class action case, direct purchasers of Suboxone, a prescription pharmaceutical used to treat addiction to opioids, sued its manufacturer (“Reckitt”) for what Judge Shwartz summarized as “anticompetitive conduct that impeded the entry of generic versions of the drug into the market,” in violation of section 2 of the Sherman Act, 15 U.S.C. 2. The District Court certified a class. Reckitt appealed, but the Third Circuit affirmed, applying the abuse of discretion standard of review. Reckitt...